Personally I don’t think the market has forgotten the saga with Her-Vaxx, never a bad trial, always good news but never got off the ground and with management quoting statements like dance partners etc a lot of people got burnt who bought following management tones.
Fast forward several years management has lost credibility and not too many people are interested in phase 1+ stuff. Revenue of any kind (partnerships, licensing etc) is the only thing that will move the needle
Ann: Imugene Confirms Pending Receipt of c.$11m R&D Tax Refund, page-78
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.3¢ |
Change
-0.001(7.14%) |
Mkt cap ! $97.07M | |||
| Open | High | Low | Value | Volume |
| 1.3¢ | 1.3¢ | 1.2¢ | $179.4K | 14.42M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 52 | 15731879 | 1.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.3¢ | 3463196 | 20 |
View Market Depth
| Last trade - 16.10pm 23/06/2025 (20 minute delay) ? |
| IMU (ASX) Chart |